Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy

• Main Authors: Sirachainan N., Nuchprayoon I., Thanarattanakorn P., Pakakasama S., Lusawat A., Visudibhan A., Dhanachai M., Larbcharoensub N., Amornfa J., Shotelersuk K., Katanyuwong K., Tangkaratt S., Hongeng S.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952186468&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/43079
• Institution: Chiang Mai University

Medulloblastoma is the most common malignant brain tumor in children. Post-surgical craniospinal irradiation (CSI; 30-36 Gy) plus local boost radiation therapy (RT; 54-56 Gy) is a standard treatment for children with medulloblastoma who are over 3 years old, resulting in a 5-year overall survival (O...